William Stager

Another Look at the Pentoxifylline Efficacy Data for Intermittent Claudication

Dennis B. Gillings, Gary G. Koch, Theobald Reich et al. · The Journal of Clinical Pharmacology · 1987 · 30 citations

Medicine, Pharmacotherapy, Clinical Pharmacology +10

Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the <scp>LixiLan‐O</scp> trial testing a titratable fixed‐ratio combination of insulin glargine/lixisenatide ( <scp>iGlarLixi</scp> ) vs insulin glargine and lixisenatide monocomponents

Melanie J. Davies, Lawrence A. Leiter, Bruno Guerci et al. · Diabetes Obesity and Metabolism · 2017 · 28 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Consistent findings in glycaemic control, body weight and hypoglycaemia with <scp>iGlarLixi</scp> (insulin glargine/lixisenatide titratable fixed‐ratio combination) vs insulin glargine across baseline <scp>HbA1c</scp> , <scp>BMI</scp> and diabetes duration categories in the <scp>LixiLan‐L</scp> trial

Carol Wysham, Riccardo C. Bonadonna, Vanita R. Aroda et al. · Diabetes Obesity and Metabolism · 2017 · 27 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Insulin glargine/lixisenatide fixed‐ratio combination improves glycaemic variability and control without increasing hypoglycaemia

Ronnie Aronson, Guillermo E. Umpierrez, William Stager et al. · Diabetes Obesity and Metabolism · 2018 · 20 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Efficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes

Yehuda Handelsman, Christina Chovanes, Terry Dex et al. · Journal of Diabetes and its Complications · 2018 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16